254 related articles for article (PubMed ID: 12713737)
21. Set7/9 impacts COL2A1 expression through binding and repression of SirT1 histone deacetylation.
Oppenheimer H; Kumar A; Meir H; Schwartz I; Zini A; Haze A; Kandel L; Mattan Y; Liebergall M; Dvir-Ginzberg M
J Bone Miner Res; 2014 Feb; 29(2):348-60. PubMed ID: 23873758
[TBL] [Abstract][Full Text] [Related]
22. Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes.
Chadjichristos C; Ghayor C; Kypriotou M; Martin G; Renard E; Ala-Kokko L; Suske G; de Crombrugghe B; Pujol JP; Galéra P
J Biol Chem; 2003 Oct; 278(41):39762-72. PubMed ID: 12888570
[TBL] [Abstract][Full Text] [Related]
23. Highly conserved proximal promoter element harbouring paired Sox9-binding sites contributes to the tissue- and developmental stage-specific activity of the matrilin-1 gene.
Rentsendorj O; Nagy A; Sinkó I; Daraba A; Barta E; Kiss I
Biochem J; 2005 Aug; 389(Pt 3):705-16. PubMed ID: 15804237
[TBL] [Abstract][Full Text] [Related]
24. HC-gp39 contributes to chondrocyte differentiation by inducing SOX9 and type II collagen expressions.
Jacques C; Recklies AD; Levy A; Berenbaum F
Osteoarthritis Cartilage; 2007 Feb; 15(2):138-46. PubMed ID: 16949314
[TBL] [Abstract][Full Text] [Related]
25. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9.
Xie WF; Zhang X; Sakano S; Lefebvre V; Sandell LJ
J Bone Miner Res; 1999 May; 14(5):757-63. PubMed ID: 10320524
[TBL] [Abstract][Full Text] [Related]
26. SOX9 directly regulates the type-II collagen gene.
Bell DM; Leung KK; Wheatley SC; Ng LJ; Zhou S; Ling KW; Sham MH; Koopman P; Tam PP; Cheah KS
Nat Genet; 1997 Jun; 16(2):174-8. PubMed ID: 9171829
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter.
Porée B; Kypriotou M; Chadjichristos C; Beauchef G; Renard E; Legendre F; Melin M; Gueret S; Hartmann DJ; Malléin-Gerin F; Pujol JP; Boumediene K; Galéra P
J Biol Chem; 2008 Feb; 283(8):4850-65. PubMed ID: 18065760
[TBL] [Abstract][Full Text] [Related]
28. Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes.
Renard E; Porée B; Chadjichristos C; Kypriotou M; Maneix L; Bigot N; Legendre F; Ollitrault D; De Crombrugghe B; Malléin-Gérin F; Moslemi S; Demoor M; Boumediene K; Galéra P
J Mol Med (Berl); 2012 Jun; 90(6):649-66. PubMed ID: 22215151
[TBL] [Abstract][Full Text] [Related]
29. Toward understanding SOX9 function in chondrocyte differentiation.
Lefebvre V; de Crombrugghe B
Matrix Biol; 1998 Mar; 16(9):529-40. PubMed ID: 9569122
[TBL] [Abstract][Full Text] [Related]
30. Enhanced hyaline cartilage matrix synthesis in collagen sponge scaffolds by using siRNA to stabilize chondrocytes phenotype cultured with bone morphogenetic protein-2 under hypoxia.
Legendre F; Ollitrault D; Hervieu M; Baugé C; Maneix L; Goux D; Chajra H; Mallein-Gerin F; Boumediene K; Galera P; Demoor M
Tissue Eng Part C Methods; 2013 Jul; 19(7):550-67. PubMed ID: 23270543
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer.
Huang W; Zhou X; Lefebvre V; de Crombrugghe B
Mol Cell Biol; 2000 Jun; 20(11):4149-58. PubMed ID: 10805756
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5.
Hattori T; Coustry F; Stephens S; Eberspaecher H; Takigawa M; Yasuda H; de Crombrugghe B
Nucleic Acids Res; 2008 May; 36(9):3011-24. PubMed ID: 18390577
[TBL] [Abstract][Full Text] [Related]
33. The transcription factor activating enhancer-binding protein epsilon (AP-2ε) regulates the core promoter of type II collagen (COL2A1).
Niebler S; Bosserhoff AK
FEBS J; 2013 Mar; 280(6):1397-408. PubMed ID: 23331625
[TBL] [Abstract][Full Text] [Related]
34. SV40 large T antigen expression driven by col2a1 regulatory sequences immortalizes articular chondrocytes but does not allow stabilization of type II collagen expression.
Steimberg N; Viengchareun S; Biehlmann F; Guénal I; Mignotte B; Adolphe M; Thenet S
Exp Cell Res; 1999 Jun; 249(2):248-59. PubMed ID: 10366424
[TBL] [Abstract][Full Text] [Related]
35. Looping mediated interaction between the promoter and 3' UTR regulates type II collagen expression in chondrocytes.
Jash A; Yun K; Sahoo A; So JS; Im SH
PLoS One; 2012; 7(7):e40828. PubMed ID: 22815835
[TBL] [Abstract][Full Text] [Related]
36. Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox-responsive elements and modulation by phenotype alteration.
Ghayor C; Herrouin JF; Chadjichristos C; Ala-Kokko L; Takigawa M; Pujol JP; Galéra P
J Biol Chem; 2000 Sep; 275(35):27421-38. PubMed ID: 10856292
[TBL] [Abstract][Full Text] [Related]
37. Involvement of nuclear factor I transcription/replication factor in the early stage of chondrocytic differentiation.
Uchihashi T; Kimata M; Tachikawa K; Koshimizu T; Okada T; Ihara-Watanabe M; Sakai N; Kogo M; Ozono K; Michigami T
Bone; 2007 Dec; 41(6):1025-35. PubMed ID: 17904922
[TBL] [Abstract][Full Text] [Related]
38. Loss of Sox9 function results in defective chondrocyte differentiation of mouse embryonic stem cells in vitro.
Hargus G; Kist R; Kramer J; Gerstel D; Neitz A; Scherer G; Rohwedel J
Int J Dev Biol; 2008; 52(4):323-32. PubMed ID: 18415932
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional mechanisms of chondrocyte differentiation.
de Crombrugghe B; Lefebvre V; Behringer RR; Bi W; Murakami S; Huang W
Matrix Biol; 2000 Sep; 19(5):389-94. PubMed ID: 10980415
[TBL] [Abstract][Full Text] [Related]
40. Sox9 expression during chondrogenesis in micromass cultures of embryonic limb mesenchyme.
Kulyk WM; Franklin JL; Hoffman LM
Exp Cell Res; 2000 Mar; 255(2):327-32. PubMed ID: 10694448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
